Recent Finacing
Recent Raise
DiamiR develops plasma-based quantitative microRNA tests (CogniMIR) that analyze brain-enriched miRNA signatures for minimally invasive early detection, patient stratification, and monitoring of neurodegenerative conditions.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor